BlueCrest Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-14,131
| Closed | -$695K | – | 1271 |
|
|
2018
Q3 | $695K | Sell |
14,131
-2,446
| -15% | -$120K | 0.02% | 577 |
|
|
2018
Q2 | $531K | Buy |
16,577
+2,421
| +17% | +$77.6K | 0.01% | 775 |
|
|
2018
Q1 | $441K | Buy |
14,156
+621
| +5% | +$19.3K | 0.01% | 818 |
|
|
2017
Q4 | $618K | Buy |
13,535
+1,007
| +8% | +$46K | 0.02% | 472 |
|
|
2017
Q3 | $470K | Buy |
12,528
+2,158
| +21% | +$81K | 0.02% | 515 |
|
|
2017
Q2 | $495K | Buy |
+10,370
| New | +$495K | 0.02% | 569 |
|